␤-Adrenergic receptors are involved in altering cerebral metabolism and blood flow. This study was performed to determine whether propranolol would alter the microregional O 2 balance in the brain. Rats were anesthetized with 1.4% isoflurane. Isotonic sodium chloride solution (control group), propranolol 2 mg/kg (low propranolol group) or propranolol 20 mg/kg (high propranolol group) was administered IV to the rats. Twenty minutes later, regional cerebral blood flow (rCBF) was measured using the 14 C-iodoantipyrine autoradiographic technique. Small (diameter Ͻ70 m) arterial and venous oxygen saturation (Sao 2 and Svo 2 , respectively) was determined using microspectrophotometry in the alternate slices of the tissue sections used to measure rCBF. In both the low and high propranolol groups, average cortical rCBF was 35% lower than that in the control group. The average O 2 consumption of the cortex of the propranolol groups was significantly lower than control (low propranolol: Ϫ41%, high propranolol: Ϫ49%). In all groups, Sao 2 was almost identi-cal. The heterogeneity of the microregional Svo 2 expressed as the coefficient of variation (CV ϭ 100 ϫ sd/mean) was significantly lower in the propranolol groups (low propranolol: 8.0 Ϯ 2.3, high propranolol: 7.3 Ϯ 2.9) than in the control group (13.4 Ϯ 3.5). The proportion of cortical veins with Svo 2 Ͻ55% was significantly smaller in the low and high propranolol groups (4 of 60 and 3 of 60, respectively) than that in the control group (15 of 60). In the other brain regions, the data followed a similar pattern. Our data demonstrated that propranolol is effective in decreasing O 2 consumption, improving microregional O 2 balance, and reducing its heterogeneity in the brain. Implications: Our data suggest that the linkage of O 2 supply and consumption is not tightly coupled under isoflurane anesthesia. ␤-Adrenergic blockers may tighten this linkage and reduce the number of low O 2 -saturated microregions.
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(Anesth Analg 1999;89:690 -5) T he hypothesis that local neuronal activity of the brain will determine the local brain blood flow is generally accepted (1). Regional venous O 2 saturation (Svo 2 ) reflects the regional balance of O 2 supply and consumption (2) (3) (4) . If microregional cerebral blood flow matches its local O 2 consumption precisely, the variation of local Svo 2 would be minimal. However, studies suggest that the linkage between local cerebral blood flow and metabolism is not tightly coupled. A marked heterogeneous distribution of Svo 2 and tissue O 2 partial pressure has been demonstrated (2-7).
The mechanism of this heterogeneity of Svo 2 is not known; however, one of the possible mechanisms could be via the sympathetic nervous system of the brain.
Blocking peripheral sympathetic innervation of the cerebral blood vessels by bilateral cervical sympathectomy causes a significant decrease in the heterogeneity of microregional O 2 saturation (7). ␤-Adrenergic agonists have been reported to increase cerebral blood flow (CBF) and cerebral metabolic rate (CMR), especially when the blood-brain barrier (BBB) is disrupted (8 -11) .
We hypothesized that one of the factors that alters the heterogeneity of cerebral microregional O 2 balance may involve ␤-adrenergic receptors. We investigated whether blocking peripheral and central ␤-adrenergic receptors could alter the heterogeneity of cerebral microregional O 2 balance by affecting CMR, CBF, or both. In this experiment, propranolol, which crosses the BBB, was used to block ␤-adrenergic receptors. Propranolol, a nonselective ␤-adrenergic blocking drug, has no intrinsic sympathomimetic action but has a membrane-stabilizing activity (12) . Propranolol decreases CBF and CMR and attenuates a cerebral vascular and metabolic response to catecholamines or some stresses (13) (14) (15) (16) . To determine CMR, most studies use a 2-deoxyglucose uptake technique, which measures the average rate of glucose use over a 45-min period. This technique fails to reflect instantaneous changes of CMR. In the present study, cryomicrospectrophotometry, which allows the determination of instantaneous changes of cerebral O 2 consumption, was used to determine microscopic Sao 2 and Svo 2 .
Methods
This study was approved by our institutional animal care and use committee. Eighteen male Long-Evans rats (320 -350 g) were divided into the following three groups of six rats each: 1) control group, 2) low propranolol group, and 3) high propranolol group. All rats were anesthetized with 1.4% isoflurane in an air and oxygen mixture (fraction of inspired oxygen 0.25-0.3), and their lungs were mechanically ventilated. A femoral artery and a femoral vein were catheterized. The femoral arterial catheter was connected to a Statham P23AA transducer (Gould Instruments, Cleveland, OH). Blood pressure was continuously monitored and recorded on a Beckman R-411 recorder (Fullerton, CA). Before determining regional cerebral blood flow (rCBF) or O 2 consumption, a 0.2-mL arterial blood sample was withdrawn anaerobically and analyzed for Pao 2 , Paco 2 , and pH using a blood gas analyzer (ABL330; Radiometer America, Westlake, OH). The hemoglobin concentration was measured using spectrophotometry. The femoral venous catheter was used to administer propranolol and radioactive tracers. Rectal temperature was monitored and maintained at 37°C by using a servocontrolled thermistor probe and a heating lamp. Pericranial temperature under the temporalis muscle was monitored using a thermocouple probe (Omega Engineering Inc., Stamford, CT) and was maintained at 37°C. For the low propranolol group, propranolol (Sigma, St. Louis, MO) 2 mg/kg was infused IV over a 1-min period, followed by isotonic sodium chloride solution administration. For the high propranolol group, propranolol 20 mg/kg was infused IV over a 10-min period. For the control group, the same volume of isotonic sodium chloride solution (approximately 2 mL) without propranolol was administered over a 10-min period.
Twenty minutes after the propranolol infusion, rCBF was measured using the 14 C-iodoantipyrine quantitative autoradiographic technique modified from Sakurada et al. (17) . Briefly, 50 Ci of 14 Ciodoantipyrine was infused IV. When the isotope entered the venous circulation, the arterial catheter was cut to a length of 20 mm to minimize smearing in the sampling catheter. A 20-L blood sample was obtained from the arterial catheter approximately every 3 s during the next 40 s. When the last sample was obtained, the animal was decapitated, and the head was frozen in liquid nitrogen. While frozen, tissue was sampled from the cortex, medulla, and putamen. These tissue samples were mounted with an embedding medium on a microtome cryostat at Ϫ35°C. Tissue slices of 20 m thickness were obtained under a nitrogen atmosphere. Autoradiograms were prepared from these sections by exposure to radiograph film in radiograph cassettes for 5 days. The cerebral 14 C tissue concentration was determined using a computerbased microdensitometer system and by reference to eight precalibrated standards (range 40 -1069 Ci/g). For each brain region examined, a minimum of eight optical density measurements were made, each on a different section. Blood samples were placed in a tissue solubilizer; 24 h later, they were put in a counting fluid. These samples were counted on a liquid scintillation counter. The isotope counts were quenchcorrected.
rCBF determinations were calculated using the equation described by Sakurada et al. (17) .
Alternate slices of the tissue sections that were used to measure rCBF were used to determine Sao 2 and Svo 2 . Details of this technique have been published previously (2) (3) (4) 18) . The tissue sections were transferred to precooled glass slides and covered with degassed silicone oil and a coverslip. These slides were placed on a microspectrophotometer fitted with a N 2 -flushed cold stage to obtain readings of optical densities at 523, 560, and 568 nm. This three-wavelength method corrects for light scattering in frozen blood. Only vessels in the transverse section were studied so that the path of light traversed only the blood. The size of the measuring spot was 8 m in diameter. Readings were obtained to determine O 2 saturation in the six to seven arteries and 9 -10 veins (20 -70 m in diameter) found in these regions. The distribution of Svo 2 was determined.
The O 2 content of blood was determined by multiplying the percentage of O 2 saturation by the hemoglobin concentration times 1.36. The difference between the average arterial and venous O 2 contents (regional O 2 extraction) was then obtained. Using the Fick principle, the paired product of O 2 extraction and blood flow was obtained to determine the regional O 2 consumption of the brain.
The coefficient of variation (CV) of Svo 2 was used to compare changes in heterogeneity. The CV was calculated as 100 ϫ sd/mean. A 2 test was used to assess differences in the distribution of Svo 2 and differences in the number of low saturated veins. A factorial analysis of variance was used to assess the differences among the groups and among the various examined regions for CBF, O 2 balance variables, and the systemic hemodynamic and blood gas variables. Post hoc testing of multiple comparisons was performed using Duncan's procedure. All values were expressed as mean Ϯ sd. Significance was defined as P Ͻ 0.05.
Results
Hemodynamic and blood gas variables of the experimental groups are presented in Table 1 . In the low propranolol group, the blood pressure was not significantly different from that of the control group. However, the heart rate was significantly lower than that of the control group (P Ͻ 0.05). In the high propranolol group, the systolic and mean blood pressures (P Ͻ 0.05) and the heart rate (P Ͻ 0.05) were significantly lower than those of the control animals. Blood gases and hemoglobin were similar in all groups.
rCBF values in the various regions of the brain of the three groups are presented in Figure 1 . In the low propranolol group, the average rCBF of the cortex (P Ͻ 0.05) or medulla (P Ͻ 0.05) was significantly lower than that of the control group. In the putamen, however, the difference was not significant between these two groups. In the high propranolol group, the rCBF of all three brain regions was significantly lower than that of the corresponding brain region of the control group (cortex: P Ͻ 0.01, medulla: P Ͻ 0.005, putamen: P Ͻ 0.05). There was no statistical difference in rCBF or other O 2 balance variables in each brain region between the low and high propranolol groups. There was no significant difference in rCBF or other O 2 balance variables among the regions in any experimental group (Table 2, Figure 1 ).
In the low propranolol group, the average Svo 2 of the cortex (P Ͻ 0.01) and the putamen (P Ͻ 0.01) was lower than that of the corresponding brain region of the control group. In the high propranolol group, in all of the brain regions studied (cortex: P Ͻ 0.01, medulla: P Ͻ 0.05, putamen: P Ͻ 0.05), the average Svo 2 was lower than that of the corresponding control brain region ( Table 2 ). The Sao 2 was almost identical (91%-93%) in all regions of all groups.
The average O 2 extraction in each brain region of the low propranolol group was not significantly different from that of the control group. In the high propranolol group, the O 2 extraction in the cerebral cortex was lower than that of the control group (P Ͻ 0.05). In the other brain regions, the difference between these two groups was not significant ( Table 2 ). In the low and high propranolol groups, the O 2 consumption of each brain region (cortex: P Ͻ 0.005, medulla: P Ͻ 0.005, putamen: P Ͻ 0.01) that was examined was significantly lower than that of the corresponding brain region of the control group (Figure 2) .
The CV of Sao 2 was 4.5-5.5 in all brain regions. The CV of Svo 2 in the low (cortex: P Ͻ 0.05, medulla: P Ͻ 0.001, putamen: P Ͻ 0.005) and high propranolol groups (cortex: P Ͻ 0.01, medulla: P Ͻ 0.001, putamen: P Ͻ 0.001) in each brain region was significantly lower than that in the corresponding brain region of the control group (Table 2 ). The number of veins with O 2 saturation Ͻ55% was significantly lower in the low (cortex: P Ͻ 0.01, medulla: P Ͻ 0.01, putamen: P Ͻ 0.01) and high propranolol groups (cortex: P Ͻ 0.005, medulla: P Ͻ 0.001, putamen: P Ͻ 0.0005) than in the control group in all brain regions studied. The percentage 55% was chosen because, in the control group, 25% of the veins had an O 2 saturation Ͻ55% (Figure 3) .
Discussion
Our data demonstrate that a small (2 mg/kg) or large dose (20 mg/kg) of propranolol significantly decreases the heterogeneity of microregional Svo 2 and decreases the number of veins with low O 2 saturation in the three brain regions studied. Our data suggest that the heterogeneity of Svo 2 may involve ␤-adrenergic receptors. Propranolol decreased the average rCBF and the average O 2 consumption in most of the brain regions studied, as previously reported (13) (14) (15) (16) .
Both CBF and CMR vary throughout the brain. The regional Svo 2 reflects the regional balance of O 2 supply and consumption because there is little variation in the regional Sao 2 (2-4). Because a marked heterogeneous distribution of Svo 2 and tissue O 2 partial pressure has been reported, the linkage between CBF and CMR may not be tightly matched (2-7). It has been reported that various anesthetics exert various effects on the heterogeneity of Svo 2 (2-4). Because every animal in the present study was anesthetized with the same concentration of isoflurane, the effects of anesthetics on the heterogeneity should be equal among the experimental animals.
The heterogeneity of cerebral microvascular Svo 2 could be changed by the sympathetic nervous system of peripheral or central origin. There is evidence that cerebral arteries and arterioles are innervated by the adrenergic system and possess ␤-adrenergic receptors (19 -22) . The peripheral sympathetic nervous system innervates the cerebral cortical area or blood vessels originating from the internal carotid artery (19) . This innervation is heterogeneous. This heterogeneous distribution of the sympathetic innervation may limit flow and may decrease red cell velocity to certain microregional areas in the cerebral cortex without decreasing global CBF and rCBF. Thus, sympathetic innervation might be one of the factors responsible for the wide variations of cerebral cortical microvascular flow and red cell velocity that were observed by other investigators (6, 23) . Nonuniform reduction in blood flow and red cell velocity within the brain may increase O 2 extraction within certain microregions, thereby broadening the heterogeneity of Svo 2 . Bilateral cervical sympathectomy causes no significant change in cortical O 2 consumption and blood flow but results in a significant decrease in the heterogeneity of microregional Svo 2 (7) .
We hypothesized that blocking ␤-adrenergic receptors could alter cerebral O 2 supply and consumption balance in a microscopic area by affecting either microregional blood flow, neuronal metabolism, or both. Propranolol has been reported to decrease CBF and CMR and to attenuate the changes in CBF and CMR in response to various stressful stimuli (13) (14) (15) (16) . We speculated that propranolol might block not only the peripheral ␤-adrenergic receptors, but also the central ␤-adrenergic receptors because it crosses the BBB. We demonstrated that propranolol significantly decreases the average CBF and the average CMR under isoflurane anesthesia. In our study, propranolol was administered to animals already anesthetized with isoflurane. The cerebral metabolic and vascular responses to propranolol may be different in awake animals. In gently restrained awake rats, propranolol induces a small decrease in rCBF in some brain structures (15) .
One of the reasons for this decrease of rCBF by propranolol could be its indirect action on blood flow through changes in the CMR. Changes in neuronal activity produced by stimulation or blockade of neuronal receptors associated with the cerebral central noradrenergic neurotransmitter system have been shown to change CMR (8, 11, 14, 16) . Because there is a close correlation between CMR and CBF, decreased CMR induced by the central ␤-adrenergic receptor blockade would have decreased CBF through metabolically mediated vasoconstriction. Propranolol may have decreased metabolism in the metabolically active microregions and may have improved microregional O 2 balance, resulting in a decreased heterogeneity of Svo 2 . In our study, the heterogeneity was significantly reduced (Ϫ40%) by propranolol. However, the average regional Svo 2 was increased by only 5% with propranolol treatment. Our data suggest that, although propranolol slightly changed the average Svo 2 , it markedly altered the microregional O 2 balance.
Another mechanism of decreased rCBF caused by propranolol could be due to a direct action on the cerebral vasculature through ␤-adrenergic receptors in the arteries or arterioles, or due to an attenuation of the vasodilatory effect of isoflurane (19 -22) . Vascular ␤-adrenergic receptors undergo rapid adaptation. They are probably less important than metabolically induced ␤-adrenergic changes (24) . This vasoconstrictive action may have not only decreased the overall CBF, but also reduced the microregional blood flow to the metabolically calm area. This may have helped the matching of blood flow and metabolism and may have subsequently lowered the number of veins with unnecessarily high O 2 saturation in the present study, resulting in the decreased heterogeneity of Svo 2 . In this study, however, O 2 extraction was not significantly altered when rCBF was reduced. Our study suggests that the primary action of propranolol in reducing rCBF is via decreasing the CMR, rather than via a direct action on the blood vessels.
Propranolol has a membrane-stabilizing activity, the so-called "local anesthetic-like effect." Because lidocaine, a local anesthetic, has been reported to decrease CBF and CMR, the local anesthetic-like effect of propranolol could have contributed to the decrease of rCBF, CMR, and heterogeneity of Svo 2 (25) .
In our study, the effects of blood pressure on CBF and the heterogeneity of O 2 saturation should have been minimal because mean arterial blood pressure (MAP) was similar between the control and smalldose propranolol groups. In the large-dose propranolol group, despite relatively lower MAP, the rCBF and heterogeneity of Svo 2 were not significantly different from those in the small-dose propranolol group. It is still possible that the decrease of rCBF in the propranolol-treated animals may be due to a decrease of cardiac output by propranolol. However, in our study, O 2 extraction was not significantly altered or was only minimally altered with propranolol treatment, despite the decrease of rCBF, which suggests that rCBF was decreased to match the decrease of CMR rather than a decrease of cardiac output. Because increasing the dose of propranolol did not significantly affect the heterogeneity of Svo 2 , rCBF, or O 2 consumption, our data suggest that there is a limitation in altering the CBF, metabolism, and the heterogeneity of Svo 2 , which are mediated through ␤-adrenergic receptors. There are other possible reasons for this heterogeneity. There could be a time delay of the metabolic supply behind the metabolic demand, variation of regional metabolism, different hematocrit, microregional variation of the ratio of O 2 supply to consumption, rheologic factors, inhomogeneous anatomic distribution of vessels and neurons, or methodologic limitations that could affect the CV of the Svo 2 by 3%-4% (18) . It is not clear whether propranolol affects these other factors, which may, in turn, change the heterogeneity. It is likely that the spatial heterogeneity of Svo 2 in the brain might originate from more than one contributing factor. Some factors may affect others or may be superimposed.
In conclusion, there is heterogeneity of the microregional O 2 balance during isoflurane anesthesia. Propranolol was effective in decreasing the heterogeneity of microregional O 2 balance and decreasing the number of veins with relatively low O 2 saturation under isoflurane anesthesia.
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